AGIOS PHARMACEUTICALS, INC. (AGIO) insider trading

By person

33 insiders · 423 transactions

8.2×

Brian Goff holds 8.2 times base salary in stock. $6.95M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $37.69, the price Common stock was last bought or sold at on the open market here, on 26 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Celgene Corp /De/ entity

10% owner

$69.53M (2)

—

+$69.53M

2,486,157

4.16%

$93.70M

+101.8%

David P Schenkein

Director

$249.98K (1)

$43.84M (63) scheduled

−$43.59M

397,014

0.6650%

$14.96M

+45.8%

Celgene European Investment Co LLC entity

10% owner

$30.92M (1)

—

+$30.92M

5,867,279

9.83%

$221.14M

+11.9%

Robert Nelsen

Director

—

$20.75M (15)

−$20.75M

109,230

0.1830%

$4.12M

−79.3%

Christopher Bowden

Chief Medical Officer

—

$12.62M (37) scheduled

−$12.62M

15,487

0.0259%

$583.71K

+1,086%

Scott Biller

Chief Scientific Officer

—

$11.81M (62) scheduled

−$11.81M

86,788

0.1454%

$3.27M

+34.5%

Brian Goff

Chief Executive Officer

—

$5.41M (19) scheduled

−$5.41M

184,508

0.3090%

$6.95M

—

Steven L. Hoerter

Chief Commercial Officer

—

$3.75M (10) scheduled

−$3.75M

10,941

0.0183%

$412.37K

—

Sarah Gheuens

Chief Medical Officer

—

$3.22M (27) scheduled

−$3.22M

54,645

0.0915%

$2.06M

+691.4%

Lewis Clayton Cantley Jr.

Director

—

$2.34M (58)

−$2.34M

158,990

0.2663%

$5.99M

−20.1%

Kaye I Foster-Cheek

Director

—

$2.24M (8) scheduled

−$2.24M

10,284

0.0172%

$387.60K

—

James William Burns

Chief Legal Officer

—

$2.10M (19) scheduled

−$2.10M

49,306

0.0826%

$1.86M

+406.2%

John Maraganore

Director

—

$2.00M (3)

−$2.00M

30,028

0.0503%

$1.13M

−53.0%

Rahul D. Ballal

Director

—

$1.12M (5) scheduled

−$1.12M

15,230

0.0255%

$574.02K

—

Theodore James Washburn Jr.

Principal Accounting Officer

—

$1.06M (24)

−$1.06M

868

0.0015%

$32.71K

−71.1%

Cecilia Jones

Chief Financial Officer

—

$895.71K (15) scheduled

−$895.71K

54,998

0.0921%

$2.07M

+2,216%

Carman Alenson

Principal Accounting Officer

—

$773.19K (12)

−$773.19K

0.0000%

$0.00

−100.0%

Tsveta Milanova

Chief Commercial Officer

—

$741.86K (11) scheduled

−$741.86K

46,829

0.0784%

$1.76M

—

Darrin Miles

Chief Commercial Officer

—

$321.70K (3)

−$321.70K

7,209

0.0121%

$271.71K

+16.5%

Krishnan Viswanadhan

Chief Strategy and Operations

—

$184.97K (2) scheduled

−$184.97K

10,282

0.0172%

$387.53K

—

Jacqualyn A Fouse

Director

$1.25M (1)

$1.14M (5) scheduled

+$112.27K

154,156

0.2582%

$5.81M

—

David Scadden

Director

$16.69K (1)

$98.22K (6) scheduled

−$81.54K

20,419

0.0342%

$769.59K

+5,404%

Andrew Hirsch

Chief Financial Officer

—

24,272

0.0407%

$914.81K

+808,967%

Jonathan Biller

Chief Financial Officer

—

22,953

0.0384%

$865.10K

+2,665%

Maykin Ho

Director

—

19,848

0.0332%

$748.07K

—

Bruce Car

Chief Scientific Officer

—

16,752

0.0281%

$631.38K

—

Cynthia Smith

Director

—

15,230

0.0255%

$574.02K

—

Adams Catherine Owen

Director

—

10,865

0.0182%

$409.50K

—

Jeffrey D Capello

Director

—

10,865

0.0182%

$409.50K

—

Richa Poddar

Chief Commercial Officer

—

8,508

0.0143%

$320.67K

+1,112%

Paul J Clancy

Director

—

6,549

0.0110%

$246.83K

—

Ian T Clark

Director

—

6,549

0.0110%

$246.83K

—

Jay T. Backstrom

Director

—

1,447

0.0024%

$54.54K

—

AGIOS PHARMACEUTICALS, INC.

What the insiders did Net buying

By person